WO2004094335A1 - Calcium phosphate cement, use and preparation thereof - Google Patents

Calcium phosphate cement, use and preparation thereof Download PDF

Info

Publication number
WO2004094335A1
WO2004094335A1 PCT/US2004/011637 US2004011637W WO2004094335A1 WO 2004094335 A1 WO2004094335 A1 WO 2004094335A1 US 2004011637 W US2004011637 W US 2004011637W WO 2004094335 A1 WO2004094335 A1 WO 2004094335A1
Authority
WO
WIPO (PCT)
Prior art keywords
ttcp
particles
treatment
whiskers
paste
Prior art date
Application number
PCT/US2004/011637
Other languages
French (fr)
Inventor
Jiin-Huey Chern Lin
Chien-Ping Ju
Wen-Cheng Chen
Kuan-Liang Lin
I-Chang Wang
Original Assignee
Calcitec, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/414,582 external-priority patent/US7094282B2/en
Application filed by Calcitec, Inc. filed Critical Calcitec, Inc.
Priority to CA002520367A priority Critical patent/CA2520367A1/en
Priority to EP04750157A priority patent/EP1613563A1/en
Priority to AU2004232948A priority patent/AU2004232948A1/en
Priority to JP2006510072A priority patent/JP2007525240A/en
Publication of WO2004094335A1 publication Critical patent/WO2004094335A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/02Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B12/00Cements not provided for in groups C04B7/00 - C04B11/00
    • C04B12/02Phosphate cements
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B12/00Cements not provided for in groups C04B7/00 - C04B11/00
    • C04B12/02Phosphate cements
    • C04B12/025Phosphates of ammonium or of the alkali or alkaline earth metals
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B28/00Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
    • C04B28/34Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
    • C04B28/344Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders the phosphate binder being present in the starting composition solely as one or more phosphates
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B28/00Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
    • C04B28/34Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
    • C04B28/346Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders the phosphate binder being present in the starting composition as a mixture of free acid and one or more phosphates
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/10Inorganic compounds or compositions
    • C30B29/14Phosphates
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/60Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape characterised by shape
    • C30B29/62Whiskers or needles
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00034Physico-chemical characteristics of the mixtures
    • C04B2111/00086Mixtures with prolonged pot-life
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00034Physico-chemical characteristics of the mixtures
    • C04B2111/00206Compositions defined by their elemental analysis
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00241Physical properties of the materials not provided for elsewhere in C04B2111/00
    • C04B2111/0025Compositions or ingredients of the compositions characterised by the crystal structure
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/00474Uses not provided for elsewhere in C04B2111/00
    • C04B2111/00836Uses not provided for elsewhere in C04B2111/00 for medical or dental applications
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991Coated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991Coated
    • Y10T428/2993Silicic or refractory material containing [e.g., tungsten oxide, glass, cement, etc.]

Definitions

  • the present invention relates generally to a calcium phosphate cement, and particularly to a fast-setting calcium phosphate cement, for use in dental and bone prosthesis.
  • CPC calcium phosphate cement
  • the prior art calcium phosphate cements suffer one or more drawbacks as follows: 1) requiring additives with a relatively poor bioactivity; 2) a complicated preparation process; 3) an undesired setting time or working time for the CPC that is difficult to adjust; 4) being incapable of setting to a desired shape in water, blood or body fluid; and 5) having poor initial strength after setting of the CPC.
  • the present invention is based on the discovery that monophasic particles of tetracalcium phosphate (TTCP) having whiskers or fine crystals on surfaces of the particles can be prepared and used to make a calcium phosphate cement suitable for preparation of bone and tooth prosthesis.
  • TTCP tetracalcium phosphate
  • the invention provides calcium phosphate cement particles comprising monophasic tetracalcium phosphate (TTCP) particles, wherein said TTCP particles on their surfaces have whiskers or fine crystals with a width ranging from 2 to 500 nm and a length ranging from 5 to 5000 nm.
  • TTCP monophasic tetracalcium phosphate
  • the invention provides methods for preparing a paste for use in treating a defect in a bone or a tooth in a patient by introducing said paste into a bone defect or bone cavity of said patient or shaping said paste and implanting the resulting shaped paste into a bone defect or a bone cavity of said patient, said method comprising mixing invention TTCP particles and a hardening aqueous solution sufficient to form a paste.
  • the invention provides methods for preparing TTCP particles comprising mixing a powder or small pieces of invention TTCP particles with a wetting agent, and controlling growth of whiskers or fine crystals of TTCP on surfaces of said TTCP powder or small pieces of TTCP by a controlling treatment, to provide whiskers or fine crystals of TTCP having a width ranging from 1 nm to 100 nm and a length ranging from 1 nm to 5000 nm.
  • the present invention provides a calcium phosphate cement comprising monophasic TTCP particles having a diameter of 0.05 to 100 microns, wherein said TTCP particles on their surfaces have whiskers or fine crystals having a width ranging from 2 to 500 nm and a length ranging from 5 to 5000 nm, for example a width ranging from 2 to 100 nm and a length ranging from 5 to 1000 nm, or a width ranging from 2 nm to about 200 nm and a length ranging from 10 nm to about 2000 nm.
  • a suitable process for preparing the calcium phosphate cement of the present invention comprises mixing a TTCP powder or small pieces of monophasic TTCP with a wetting agent, and controlling growth of whiskers or fine crystals on surfaces of said TTCP powder or small pieces of TTCP by an controlling treatment.
  • the shape of the monophasic small pieces of TTCP or grains of TTCP powder are not limited, and can include spherical or irregular shapes; and the crystal structure thereof can be single crystal, polycrystal, mixed crystals, semi-crystal, or amorphous.
  • Suitable wetting agents used to wet the powder or small pieces of TTCP include any aqueous solution comprising alkaline ions (for example, sodium(Na) or potassium(K) ions); alkaline earth ions (for example, magnesium(Mg) or calcium(Ca)
  • the wetting agent used is a diluted aqueous solution containing phosphoric acid or phosphate.
  • the amount of the wetting agent mixed with the monophasic TTCP powder or small pieces should be enough to substantially wet all the TTCP powder or small pieces of TTCP.
  • the controlling treatment is the organic solvent treatment, where a water miscible organic solvent is added to the mixture of said wetting agent and the TTCP powder or small pieces of TTCP to form a paste for a subsequent processing step.
  • a dilute aqueous solution containing more than 20 ppm of phosphoric acid or phosphate, more preferably more than 50 ppm, and most preferably more than 100 ppm of phosphoric acid or phosphate can be mixed with the monophasic TTCP particles or powder prior to the controlling treatment.
  • the controlling treatment is selected from a vacuuming treatment, an organic solvent treatment, a microwave treatment, a heating treatment, or any other treatments that can control growth of whiskers or fine crystals on surfaces of monophasic TTCP powder or small pieces. Due to its simplicity and effectiveness, the most frequently used controlling treatment is heating to about 50 °C for 1 day. [0013]
  • the process for preparing the calcium phosphate cement can further comprise grinding the resulting product from the controlling treatment to form TTCP particles having a diameter of 0.05 to 100 microns, wherein said whiskers or fine crystals of TTCP have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
  • the process for preparing the calcium phosphate cement of the present invention comprises soaking said TTCP powder or said small pieces of TTCP with a diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out (a) a heating treatment comprising drying the resulting soaked TTCP powder or soaked small pieces of TTCP at a temperature in the range from about 50°C to about ; (b) a vacuuming treatment comprising drying the resulting soaked TTCP powder or soaked small pieces of TTCP under vacuum; or (c) a microwave treatment comprising drying the resulting soaked-TTCP powder or soaked small pieces of TTCP by microwave heating. More preferably, the resulting soaked TTCP powder or soaked small pieces of TTCP are well mixed to form a uniform mixture prior to being subjected to treatment (a), (b) or (c).
  • the process for preparing the calcium phosphate cement of the present invention comprises mixing the TTCP powder or the small pieces of TTCP with the diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out the organic solvent treatment comprising mixing the mixture of the wetting agent and the TTCP powder or small pieces of TTCP with a water miscible organic solvent, and drying the resulting mixture under vacuum.
  • the organic solvent treatment is carried out while stirring, and more preferably, the mixture of the diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate and the TTCP powder or small pieces of TTCP is well mixed prior to being subjected to the organic solvent treatment.
  • the TTCP particles of the calcium phosphate cement of the present invention have a diameter of 0.2 to 80 microns, and more preferably 0.5 to 50 microns.
  • the " width" of a whisker means an average value of lateral cross- sectional diameters of the whisker
  • the "width" of a fine crystal means an average value of the first 30% of the diameters of the fine crystal, which are shorter than the other 70% thereof.
  • the "length" of a fine crystal means an average value of the last 30% of the diameters of the fine crystal, which are longer than the other 70% thereof.
  • the whiskers or fine crystals of TTCP have a width ranging from 2 to 70 nm and a length ranging from 5 to 800 nm, and more preferably a length ranging from 10 to 700 nm.
  • the TTCP particles have a molar ratio of calcium to phosphate ranging from 0.5 to 2.5, more preferably 0.8 to 2.3, and most preferably 1.0 to 2.2.
  • the calcium phosphate cement of the present invention is biocompatible and a paste made therefrom is non-dispersive in water.
  • the paste has a working time from several minutes to hours and a setting time from a few minutes to hours. Consequently, the calcium phosphate cement of the present invention is extremely suitable for use as an implant or filling material in dental or bone prostheses, where the paste must contact water, blood or body fluid when implanted.
  • the paste made from the calcium phosphate cement of the invention is suitable for direct injection into a bone defect or cavity as an implant or filling material.
  • the present invention also discloses a method of treating a defect in bone or a tooth in a patient, by mixing the calcium phosphate cement of the present invention with a hardening -promoter-containing aqueous solution to form a paste, and a) injecting the paste into a bone defect or cavity of said patient or b) shaping the paste and implanting the resulting shaped paste into a bone defect or cavity of the patient.
  • the calcium phosphate cement may further comprise an agent that promotes bone growth, such as a growth factor, a bone morphology protein or a pharmaceutical carrier, or the hardening-promoter-containing aqueous solution can further comprises such an agent, for example, a growth factor, a bone morphology protein or a pharmaceutical carrier.
  • an agent that promotes bone growth such as a growth factor, a bone morphology protein or a pharmaceutical carrier
  • the hardening-promoter-containing aqueous solution can further comprises such an agent, for example, a growth factor, a bone morphology protein or a pharmaceutical carrier.
  • the hardening-promoter-containing aqueous solution can further comprise any known compound or composition that promotes the solidification of calcium phosphate, for example phosphates, calcium salts, and fluorides.
  • the hardening- promoter-containing aqueous solution may be an aqueous solution comprising phosphate ions, calcium ions, fluorine ions, or phosphate ions together with additional fluorine ions as a hardening promoter.
  • the amount of the hardening promoter in the hardening-promoter-containing aqueous solution has no special limitation, but preferably the concentration of the hardening promoter therein ranges from 0.1 M to 8 M, and more preferably from 1 M to 6 M.
  • the mixing ratio of the calcium phosphate cement of the present invention and the hardening-promoter-containing aqueous solution is not restricted to any particular ranges; however, the amount of said hardening-promoter-containing aqueous solution in the mixture should be sufficient to provide substantial wetting of the calcium phosphate cement of the present invention. It should be noted that more water can be supplied in- situ from saliva or body fluid when the paste is injected or implanted into the bone defect or cavity. Furthermore, the amount of the hardening promoter in the hardening-promoter- containing aqueous solution should be adjusted to a higher level when a lesser amount of said hardening-promoter-containing aqueous solution is used in the mixture.
  • a "subject" as the term is used herein is any mammal, including zoo, farm and domestic animals and humans.
  • an "effective amount" of the injectable calcium-phosphate-based bone substitute as the term is used herein is an amount effective to accomplish fusion of vertebrae adjacent to the interbody site in the subject.
  • Setting time is the time after which a 1 mm diameter pin with a load of 1/4 pound can be inserted only 1 mm deep into the surface of a CPC paste, as determined using ISO 1566, a method commonly used for measuring the setting time of dental zinc phosphate cements as well as CPC
  • Working time as the term is used herein means the time after which a CPC paste becomes too viscous to be stirred. Generally working time is a few minutes shorter than setting time.
  • the CPC paste made by the invention methods has a minimum compressive strength of about 10 MPa and a minimum compressive strength of 25 MPa is obtained within 24 hours after exposure to physiological conditions.
  • the compressive strength herein is as determined using ASTM F451-99, a method, that is commonly used for the compressive strength measurement of CPC.
  • An injectable formulation of the invention CPC paste can be introduced into a defect in a bone or tooth using any method known in the art and will have working and setting times of about 5 to about 30 minutes. About 30 minutes after introduction into the defect or after exposure to biological conditions, the invention CPC paste will form a substance with a minimum compressive strength of about 10 MPa, or a minimum of 25 MPa compressive strength within 24 hours. Additionally, when solidified, the bone substitute produced from the invention CPC paste can have a porosity of about 20% to about 50% by volume as measured using ASTM C830-00 water saturation technique.
  • the CPC paste having these characteristics can consist essentially of calcium phosphate, for example being a substantially monophasic TTCP, and is made from invention particles of monophasic TTCP having surface whiskers or fine needles of calcium phosphate, said whiskers having a length ranging from 1 to about 1000 nm and a width ranging from 1 to about 100 nm as described herein.
  • TTCP monophasic particles The most-frequently used wetting agent used in preparation of the invention TTCP monophasic particles is (NH 4 ) HPO 4 with a concentration range 0.1 - 8M, preferably 1 - 6M.
  • the length of exposure to the wetting agent will also affect the composition of the particles. For example, when TTCP monophasic particles are treated by exposure to (NH4) 2 HPO 4 for 10 min, the whiskers formed are of monophasic TTCP. However, when the same TTCP monophasic particles are treated by exposure to (NH 4 ) HPO for 24 hours the whiskers become pure hydroxyapatite.

Abstract

Monophasic TTCP particles having surfaces covered with whiskers or fine crystals with a width ranging from 2 to 500 nm and a length ranging from 5 to 5000 nm are provided and methods for their preparation. In another embodiment, methods are provided for using such monophasic TTCP particles to prepare a calcium phosphate cement having the consistency of paste that sets to form a substance with a compressive strength of about 10 MPa after setting for about 30 minutes and a compressive strength of about 25 MPa within 24 hours of exposure to in vivo conditions. The paste can be used directly to treat a defect in a bone or a tooth in a patient or the paste can be shaped and implanted into the defect.

Description

CALCIUM PHOSPHATE CEMENT, USE
AND PREPARATION THEREOF
FIELD OF THE INVENTION
[0001] The present invention relates generally to a calcium phosphate cement, and particularly to a fast-setting calcium phosphate cement, for use in dental and bone prosthesis.
BACKGROUND OF THE INVENTION
[0002] A calcium phosphate cement (abbreviated as CPC) has been widely used as an implant or filling material in dental and bone prostheses, and details of its technical description can be found in many patents, for example, U.S. Patent Nos. 4,959,104; 5,092,888; 5,180,426; 5,262,166; 5,336,264; 5,525,148; 5,053,212; 5,149,368; 5,342,441; 5,503,164; 5,542,973; 5,545,254; 5,695,729 and 5,814,681. In general, the prior art calcium phosphate cements suffer one or more drawbacks as follows: 1) requiring additives with a relatively poor bioactivity; 2) a complicated preparation process; 3) an undesired setting time or working time for the CPC that is difficult to adjust; 4) being incapable of setting to a desired shape in water, blood or body fluid; and 5) having poor initial strength after setting of the CPC.
SUMMARY OF THE INVENTION
[0003] The present invention is based on the discovery that monophasic particles of tetracalcium phosphate (TTCP) having whiskers or fine crystals on surfaces of the particles can be prepared and used to make a calcium phosphate cement suitable for preparation of bone and tooth prosthesis.
[0004] In one embodiment, the invention provides calcium phosphate cement particles comprising monophasic tetracalcium phosphate (TTCP) particles, wherein said TTCP particles on their surfaces have whiskers or fine crystals with a width ranging from 2 to 500 nm and a length ranging from 5 to 5000 nm.
[0005] In another embodiment, the invention provides methods for preparing a paste for use in treating a defect in a bone or a tooth in a patient by introducing said paste into a bone defect or bone cavity of said patient or shaping said paste and implanting the resulting shaped paste into a bone defect or a bone cavity of said patient, said method comprising mixing invention TTCP particles and a hardening aqueous solution sufficient to form a paste.
[0006] In still another embodiment, the invention provides methods for preparing TTCP particles comprising mixing a powder or small pieces of invention TTCP particles with a wetting agent, and controlling growth of whiskers or fine crystals of TTCP on surfaces of said TTCP powder or small pieces of TTCP by a controlling treatment, to provide whiskers or fine crystals of TTCP having a width ranging from 1 nm to 100 nm and a length ranging from 1 nm to 5000 nm.
DETAILED DESCRIPTION OF THE INVENTION
[0007] The present invention provides a calcium phosphate cement comprising monophasic TTCP particles having a diameter of 0.05 to 100 microns, wherein said TTCP particles on their surfaces have whiskers or fine crystals having a width ranging from 2 to 500 nm and a length ranging from 5 to 5000 nm, for example a width ranging from 2 to 100 nm and a length ranging from 5 to 1000 nm, or a width ranging from 2 nm to about 200 nm and a length ranging from 10 nm to about 2000 nm.
[0008] By adjusting the diameter of the TTCP particles, the width and/or the length of the whiskers or fine crystals, the working time and/or the setting time of the calcium phosphate cement of can be adjusted to conform to requirements for various purposes. Moreover, the calcium phosphate cement of the present invention is fast-setting, and is non-dispersive in water or an aqueous solution. [0009] A suitable process for preparing the calcium phosphate cement of the present invention comprises mixing a TTCP powder or small pieces of monophasic TTCP with a wetting agent, and controlling growth of whiskers or fine crystals on surfaces of said TTCP powder or small pieces of TTCP by an controlling treatment. The shape of the monophasic small pieces of TTCP or grains of TTCP powder are not limited, and can include spherical or irregular shapes; and the crystal structure thereof can be single crystal, polycrystal, mixed crystals, semi-crystal, or amorphous.
[0010] Suitable wetting agents used to wet the powder or small pieces of TTCP include any aqueous solution comprising alkaline ions (for example, sodium(Na) or potassium(K) ions); alkaline earth ions (for example, magnesium(Mg) or calcium(Ca)
1 9 1 ions); fluorine(F) ion; chlorine (CI)" ion; carbonate (CO )" ion, nitrate (NO3)" ion, acetate (CH3COO) _1 ion; phosphate (PO4)"3 ion; ammonium ion (NH4) +, hydrogen (H) + ion, or hydroxyl (OH)" ion. Preferably, however, the wetting agent used is a diluted aqueous solution containing phosphoric acid or phosphate.
[0011] The amount of the wetting agent mixed with the monophasic TTCP powder or small pieces, in general, should be enough to substantially wet all the TTCP powder or small pieces of TTCP. However, it is not necessarily the case when the controlling treatment is the organic solvent treatment, where a water miscible organic solvent is added to the mixture of said wetting agent and the TTCP powder or small pieces of TTCP to form a paste for a subsequent processing step. For example, a dilute aqueous solution containing more than 20 ppm of phosphoric acid or phosphate, more preferably more than 50 ppm, and most preferably more than 100 ppm of phosphoric acid or phosphate can be mixed with the monophasic TTCP particles or powder prior to the controlling treatment.
[0012] The controlling treatment is selected from a vacuuming treatment, an organic solvent treatment, a microwave treatment, a heating treatment, or any other treatments that can control growth of whiskers or fine crystals on surfaces of monophasic TTCP powder or small pieces. Due to its simplicity and effectiveness, the most frequently used controlling treatment is heating to about 50 °C for 1 day. [0013] The process for preparing the calcium phosphate cement can further comprise grinding the resulting product from the controlling treatment to form TTCP particles having a diameter of 0.05 to 100 microns, wherein said whiskers or fine crystals of TTCP have a width ranging from 1 to 100 nm and a length ranging from 1 to 1000 nm.
[0014] Preferably, the process for preparing the calcium phosphate cement of the present invention comprises soaking said TTCP powder or said small pieces of TTCP with a diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out (a) a heating treatment comprising drying the resulting soaked TTCP powder or soaked small pieces of TTCP at a temperature in the range from about 50°C to about ; (b) a vacuuming treatment comprising drying the resulting soaked TTCP powder or soaked small pieces of TTCP under vacuum; or (c) a microwave treatment comprising drying the resulting soaked-TTCP powder or soaked small pieces of TTCP by microwave heating. More preferably, the resulting soaked TTCP powder or soaked small pieces of TTCP are well mixed to form a uniform mixture prior to being subjected to treatment (a), (b) or (c).
[0015] Alternatively, the process for preparing the calcium phosphate cement of the present invention comprises mixing the TTCP powder or the small pieces of TTCP with the diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate, and carrying out the organic solvent treatment comprising mixing the mixture of the wetting agent and the TTCP powder or small pieces of TTCP with a water miscible organic solvent, and drying the resulting mixture under vacuum. Preferably, the organic solvent treatment is carried out while stirring, and more preferably, the mixture of the diluted aqueous solution containing more than 100 ppm of phosphoric acid or phosphate and the TTCP powder or small pieces of TTCP is well mixed prior to being subjected to the organic solvent treatment.
[0016] Preferably, the TTCP particles of the calcium phosphate cement of the present invention have a diameter of 0.2 to 80 microns, and more preferably 0.5 to 50 microns.
[0017] As used herein, the" width" of a whisker means an average value of lateral cross- sectional diameters of the whisker, and the "width" of a fine crystal means an average value of the first 30% of the diameters of the fine crystal, which are shorter than the other 70% thereof. As used herein, the "length" of a fine crystal means an average value of the last 30% of the diameters of the fine crystal, which are longer than the other 70% thereof.
[0018] Preferably, the whiskers or fine crystals of TTCP have a width ranging from 2 to 70 nm and a length ranging from 5 to 800 nm, and more preferably a length ranging from 10 to 700 nm.
[0019] Preferably, the TTCP particles have a molar ratio of calcium to phosphate ranging from 0.5 to 2.5, more preferably 0.8 to 2.3, and most preferably 1.0 to 2.2.
[0020] The calcium phosphate cement of the present invention is biocompatible and a paste made therefrom is non-dispersive in water. The paste has a working time from several minutes to hours and a setting time from a few minutes to hours. Consequently, the calcium phosphate cement of the present invention is extremely suitable for use as an implant or filling material in dental or bone prostheses, where the paste must contact water, blood or body fluid when implanted. In one embodiment, the paste made from the calcium phosphate cement of the invention is suitable for direct injection into a bone defect or cavity as an implant or filling material.
[0021] The present invention also discloses a method of treating a defect in bone or a tooth in a patient, by mixing the calcium phosphate cement of the present invention with a hardening -promoter-containing aqueous solution to form a paste, and a) injecting the paste into a bone defect or cavity of said patient or b) shaping the paste and implanting the resulting shaped paste into a bone defect or cavity of the patient.
[0022] In one embodiment of the invention methods, the calcium phosphate cement may further comprise an agent that promotes bone growth, such as a growth factor, a bone morphology protein or a pharmaceutical carrier, or the hardening-promoter-containing aqueous solution can further comprises such an agent, for example, a growth factor, a bone morphology protein or a pharmaceutical carrier.
[0023] The hardening-promoter-containing aqueous solution can further comprise any known compound or composition that promotes the solidification of calcium phosphate, for example phosphates, calcium salts, and fluorides. For example, the hardening- promoter-containing aqueous solution may be an aqueous solution comprising phosphate ions, calcium ions, fluorine ions, or phosphate ions together with additional fluorine ions as a hardening promoter.
[0024] The amount of the hardening promoter in the hardening-promoter-containing aqueous solution has no special limitation, but preferably the concentration of the hardening promoter therein ranges from 0.1 M to 8 M, and more preferably from 1 M to 6 M.
[0025] The mixing ratio of the calcium phosphate cement of the present invention and the hardening-promoter-containing aqueous solution is not restricted to any particular ranges; however, the amount of said hardening-promoter-containing aqueous solution in the mixture should be sufficient to provide substantial wetting of the calcium phosphate cement of the present invention. It should be noted that more water can be supplied in- situ from saliva or body fluid when the paste is injected or implanted into the bone defect or cavity. Furthermore, the amount of the hardening promoter in the hardening-promoter- containing aqueous solution should be adjusted to a higher level when a lesser amount of said hardening-promoter-containing aqueous solution is used in the mixture.
[0026] A "subject" as the term is used herein is any mammal, including zoo, farm and domestic animals and humans.
[0027] An "effective amount" of the injectable calcium-phosphate-based bone substitute as the term is used herein is an amount effective to accomplish fusion of vertebrae adjacent to the interbody site in the subject.
[0028] "Setting time" as the term is used herein is the time after which a 1 mm diameter pin with a load of 1/4 pound can be inserted only 1 mm deep into the surface of a CPC paste, as determined using ISO 1566, a method commonly used for measuring the setting time of dental zinc phosphate cements as well as CPC [0029] "Working time" as the term is used herein means the time after which a CPC paste becomes too viscous to be stirred. Generally working time is a few minutes shorter than setting time.
[0030] After setting for about 30 minutes, the CPC paste made by the invention methods has a minimum compressive strength of about 10 MPa and a minimum compressive strength of 25 MPa is obtained within 24 hours after exposure to physiological conditions. The compressive strength herein is as determined using ASTM F451-99, a method, that is commonly used for the compressive strength measurement of CPC.
[0031] An injectable formulation of the invention CPC paste can be introduced into a defect in a bone or tooth using any method known in the art and will have working and setting times of about 5 to about 30 minutes. About 30 minutes after introduction into the defect or after exposure to biological conditions, the invention CPC paste will form a substance with a minimum compressive strength of about 10 MPa, or a minimum of 25 MPa compressive strength within 24 hours. Additionally, when solidified, the bone substitute produced from the invention CPC paste can have a porosity of about 20% to about 50% by volume as measured using ASTM C830-00 water saturation technique.
[0032] The CPC paste having these characteristics can consist essentially of calcium phosphate, for example being a substantially monophasic TTCP, and is made from invention particles of monophasic TTCP having surface whiskers or fine needles of calcium phosphate, said whiskers having a length ranging from 1 to about 1000 nm and a width ranging from 1 to about 100 nm as described herein.
[0033] The following examples are meant to illustrate an embodiment of the invention and not to limit the scope of the invention.
EXAMPLE 1
[0034] The most-frequently used wetting agent used in preparation of the invention TTCP monophasic particles is (NH4) HPO4 with a concentration range 0.1 - 8M, preferably 1 - 6M. The length of exposure to the wetting agent will also affect the composition of the particles. For example, when TTCP monophasic particles are treated by exposure to (NH4)2HPO4 for 10 min, the whiskers formed are of monophasic TTCP. However, when the same TTCP monophasic particles are treated by exposure to (NH4) HPO for 24 hours the whiskers become pure hydroxyapatite.
[0035] The working and setting times for the CPC cement derived from TTCP particles being treated in (NH4)2HPO4 for 5-10 min (maximum strength obtained) are about 7 and 9 min, respectively. The water solubility for such CPC paste is only about 0.65% in weight after immersing the hardened cement in 37 °C deionized water for 568 hours.
EXAMPLE 2
[0036] The following tables demonstrate the relationship between compressive strength of CPC paste subjected to physiological conditions (exposure to Hank's solution for one day) when the TTCP particles used to make the CPC paste are treated for growth of whiskers for varying amounts of time resulting in whiskers of various size.
Figure imgf000009_0001
Figure imgf000009_0002
The CPC was immersed in Hanks' solution for one day before being tested for compressive strength. These studies show the compressive strength of CPC prepared from the whisker-treated TTCP powder increases with treating time until a maximum strength is obtained. When treated further, the strength declines due to "overgrowing" of the whiskers.
[0037] Although the invention has been described with respect to specific embodiments, it will be understood that modifications and variations are encompassed within the spirit and scope of the invention. Accordingly, the invention is limited only by the following claims.

Claims

WHAT IS CLAIMED IS:
1. Calcium phosphate cement particles comprising monophasic tetracalcium phosphate (TTCP) particles, wherein said TTCP particles on their surfaces have whiskers or fine crystals with a width ranging from 2 to 500 nm and a length ranging from 5 to 5000 nm.
2. The calcium phosphate cement particles of claim 1 , wherein said TTCP particles have a diameter of 0.2 to 80 microns.
3. The calcium phosphate cement particles of claim 2, wherein said TTCP particles have a diameter of 0.5 to 50 microns.
4. The calcium phosphate cement particles of claims 1, 2 or 3, wherein said whiskers or fine crystals have a width ranging from 2 to about 100 nm. and a length ranging from 5 to 1000 nm.
5. The calcium phosphate cement particles of claim 4, wherein said whiskers or fine crystals of TTCP have a width ranging from about 2 nm to about 200 nm and a length ranging from 10 nm to about 2000 nm.
6. The calcium phosphate cement particles of claim 1, wherein the whiskers are monophasic TTCP.
7. A method of preparing a paste for use in treating a defect in a bone or a tooth in a patient by introducing said paste into a bone defect or a bone cavity of said patient or shaping said paste and implanting the resulting shaped paste into a bone defect or a bone cavity of said patient, said method comprising mixing calcium phosphate cement particles of claim 1 and a hardening aqueous solution sufficient to form a paste.
8. The method of claim 7, wherein said hardening aqueous solution comprises phosphate ions, calcium ions, fluorine ions, or phosphate ions together with fluorine ions as a hardening promoter.
9. The method of claims 7 or 8, wherein said hardening aqueous solution has a concentration of 1 mM to 10 M of said hardening promoter.
10. The method of claim 9, wherein said hardening aqueous solution has a concentration of 10 mM to 6 M of said hardening promoter and the hardening promoter is (NH4)2HPO4.
11. The method according to any claim of claims 7 to 10, wherein said particles have a diameter of 0.2 to 80 microns, and said whiskers or fine crystals have a width ranging from 2 to 70 nm and a length ranging from 5 to 800 nm.
12. The method of claim 11 , wherein said particles have a diameter of 0.5 to 50 microns, and said whiskers or fine crystals have a length ranging from 10 to 700 nm.
13. The method according to any claim of claims 7 to 10, further comprising introducing a growth factor, a bone morphology protein or a pharmaceutical carrier into the hardening aqueous solution or said TTCP cement.
14. The method of claim 13, wherein the paste has a minimum compressive strength of 10 MPa or about 30 minutes after being introduced to a defect in a bone or tooth in a patient.
15. The method of claim 13, wherein the paste has a minimum compressive strength of about 25 MPa about 24 hours after being introduced to a defect in a bone or tooth in a patient
16. A method comprising mixing a powder or small pieces of monophasic TTCP with a wetting agent, and controlling growth of whiskers or fine crystals on surfaces of said powder or small pieces of TTCP by a controlling treatment, to provide whiskers or fine crystals having a width ranging from 1 nm to 100 nm and a length ranging from 1 nm to 5000 nm.
17. The method of claim 16, wherein growth of said whiskers or fine crystals is controlled to a length ranging from 10 nm to 700 nm.
18. The method of claim 16 further comprising grinding the product resulting from the controlling treatment to form monophasic TTCP particles having a diameter of 0.05 to 100 microns.
19. The method of claim 18, wherein said TTCP particles have a diameter of 0.2 to 80 microns.
20. The method of claim 19, wherein said TTCP particles have a diameter of 0.5 to 50 microns.
21. The method according to any claim of claims 7 to 20, wherein said wetting agent is an aqueous solution comprising more than 20 ppm of phosphoric acid or phosphate.
22. The method of claim 21 , wherein said wetting agent is an aqueous solution comprising about 1 to 6 M (NH4)2HPO4 and the controlling treatment is exposure to the solution for about 5 to 10 minutes.
23. The method according to any claim of claims 16 to 22, wherein said controlling treatment is selected from a vacuum treatment, an organic solvent treatment, a microwave treatment, and a heating treatment.
24. The method of claim 23, wherein said TTCP powder or said small pieces of TTCP are soaked with said wetting agent, and said controlling treatment is a heating treatment comprising drying the resulting soaked powder or small pieces of TTCP at a temperature from 45 °C to about 1000 °C.
25. The method of claim 23, wherein said TTCP powder or said small pieces of TTCP are soaked with said wetting agent, and said controlling treatment is a vacuum treatment comprising drying the soaked powder or small pieces of TTCP under vacuum.
26. The method of claim 23, wherein said TTCP powder or said small pieces of TTCP are soaked with said wetting agent, and said controlling treatment is a microwave treatment comprising drying the soaked powder or small pieces of TTCP by microwave heating.
27. The method of claim 23, wherein said controlling treatment is an organic solvent treatment comprising mixing said wetting agent and said powder or small pieces of TTCP with a water miscible organic solvent, and drying the resulting mixture under vacuum.
28. The method of claim 13, wherein said calcium phosphate cement further comprises a growth factor, a bone morphology protein or a pharmaceutical carrier.
29. The method of claim 13, wherein said hardening-promoter-containing aqueous solution further comprises a growth factor, a bone morphology protein or a pharmaceutical carrier.
PCT/US2004/011637 2003-04-16 2004-04-16 Calcium phosphate cement, use and preparation thereof WO2004094335A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002520367A CA2520367A1 (en) 2003-04-16 2004-04-16 Calcium phosphate cement, use and preparation thereof
EP04750157A EP1613563A1 (en) 2003-04-16 2004-04-16 Calcium phosphate cement, use and preparation thereof
AU2004232948A AU2004232948A1 (en) 2003-04-16 2004-04-16 Calcium phosphate cement, use and preparation thereof
JP2006510072A JP2007525240A (en) 2003-04-16 2004-04-16 Calcium phosphate cement and its usage and formulation.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/414,582 2003-04-16
US10/414,582 US7094282B2 (en) 2000-07-13 2003-04-16 Calcium phosphate cement, use and preparation thereof
US10/607,203 2003-06-27
US10/607,023 US6960249B2 (en) 1999-07-14 2003-06-27 Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface

Publications (1)

Publication Number Publication Date
WO2004094335A1 true WO2004094335A1 (en) 2004-11-04

Family

ID=33313093

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/011637 WO2004094335A1 (en) 2003-04-16 2004-04-16 Calcium phosphate cement, use and preparation thereof

Country Status (3)

Country Link
US (3) US6960249B2 (en)
EP (1) EP1613563A1 (en)
WO (1) WO2004094335A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009096709A2 (en) * 2008-01-30 2009-08-06 Snu R & Db Foundation Bone cement with anion

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169373B2 (en) * 1999-07-14 2007-01-30 Calcitec, Inc. Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same
US7094282B2 (en) * 2000-07-13 2006-08-22 Calcitec, Inc. Calcium phosphate cement, use and preparation thereof
US6840995B2 (en) * 1999-07-14 2005-01-11 Calcitec, Inc. Process for producing fast-setting, bioresorbable calcium phosphate cements
US7270705B2 (en) * 1999-07-14 2007-09-18 Jiin-Huey Chern Lin Method of increasing working time of tetracalcium phosphate cement paste
US6960249B2 (en) * 1999-07-14 2005-11-01 Calcitec, Inc. Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface
US7182928B2 (en) * 2000-07-13 2007-02-27 Calcitec, Inc. Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same
US7156915B2 (en) * 2000-07-13 2007-01-02 Calcitec, Inc. Tetracalcium phosphate (TTCP) with surface whiskers and method of making same
US20030216777A1 (en) * 2002-05-16 2003-11-20 Yin-Chun Tien Method of enhancing healing of interfacial gap between bone and tendon or ligament
US7163651B2 (en) * 2004-02-19 2007-01-16 Calcitec, Inc. Method for making a porous calcium phosphate article
US7118705B2 (en) * 2003-08-05 2006-10-10 Calcitec, Inc. Method for making a molded calcium phosphate article
US6994726B2 (en) * 2004-05-25 2006-02-07 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
WO2005046440A2 (en) * 2003-11-07 2005-05-26 Calcitec, Inc. Spinal fusion procedure using an injectable bone substitute
PT1753748E (en) 2004-05-12 2009-08-28 Pfizer Prod Inc Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
US7312989B2 (en) * 2004-12-06 2007-12-25 Chenbro Micom Co., Ltd. Cooler
EP3517137A1 (en) 2005-11-14 2019-07-31 Biomet 3I, LLC Deposition of discrete nanoparticles on an implant surface
US7972648B2 (en) * 2006-10-24 2011-07-05 Biomet 3I, Llc Deposition of discrete nanoparticles on a nanostructured surface of an implant
WO2009097218A1 (en) 2008-01-28 2009-08-06 Biomet 3I, Llc Implant surface with increased hydrophilicity
TWI427050B (en) * 2009-06-12 2014-02-21 Univ Kaohsiung Medical Calcium phosphate bone cement, precursor thereof and fabrication method thereof
US8641418B2 (en) 2010-03-29 2014-02-04 Biomet 3I, Llc Titanium nano-scale etching on an implant surface
WO2012054010A1 (en) * 2010-10-19 2012-04-26 Jiin-Huey Chern Lin Bone cement formula and bioresorbable hardened bone cement composites prepared with the same
US9867996B2 (en) 2011-11-16 2018-01-16 Btl Holdings Limited Methods and systems for skin treatment
US9115024B2 (en) 2012-02-29 2015-08-25 Macael, Inc. Radial coal ash based micro-architectures and method of synthesis
ES2671740T3 (en) 2012-03-20 2018-06-08 Biomet 3I, Llc Treatment surface for an implant surface
US9962553B2 (en) 2015-03-04 2018-05-08 Btl Holdings Limited Device and method for contactless skin treatment
CN112226218B (en) * 2020-11-06 2022-07-01 西南石油大学 Composite toughening channeling-preventing agent suitable for oil well cement and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496399A (en) * 1994-08-23 1996-03-05 Norian Corporation Storage stable calcium phosphate cements

Family Cites Families (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US578971A (en) * 1897-03-16 Trace-carrier
US3679360A (en) 1970-06-26 1972-07-25 Nasa Process for the preparation of brushite crystals
JPS577856A (en) * 1980-06-13 1982-01-16 Mitsubishi Mining & Cement Co Manufacture of calcium phosphate porous body
US4553272A (en) 1981-02-26 1985-11-19 University Of Pittsburgh Regeneration of living tissues by growth of isolated cells in porous implant and product thereof
US4518430A (en) * 1982-04-29 1985-05-21 American Dental Association Health Foundation Dental resptorative cement pastes
USRE33161E (en) * 1982-04-29 1990-02-06 American Dental Association Health Foundation Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements
USRE33221E (en) * 1982-04-29 1990-05-22 American Dental Association Health Foundation Dental restorative cement pastes
GB2132991B (en) 1982-12-14 1987-03-18 Mitsui Toatsu Chemicals Process for preparing apatite
US4612053A (en) * 1983-10-06 1986-09-16 American Dental Association Health Foundation Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements
EP0164483B1 (en) 1984-06-12 1989-08-16 Oscobal Ag Method of producing a bone replacement material
US5335264A (en) * 1985-07-09 1994-08-02 Alpine Electronics, Inc. Method and apparatus for monitoring sound within a vehicle by telephone
JPS62182146A (en) * 1985-10-11 1987-08-10 三井東圧化学株式会社 Hardenable material
JP2572606B2 (en) * 1987-09-14 1997-01-16 旭光学工業株式会社 Manufacturing method of superficially porous calcium phosphate ceramics
US5180426A (en) 1987-12-28 1993-01-19 Asahi Kogaku Kogyo K.K. Composition for forming calcium phosphate type setting material and process for producing setting material
US5342411A (en) * 1988-04-16 1994-08-30 Greater Glasgow Health Board Scalp cooling device
US6005162A (en) 1988-04-20 1999-12-21 Norian Corporation Methods of repairing bone
US5053212A (en) * 1988-04-20 1991-10-01 Norian Corporation Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
US4880610A (en) * 1988-04-20 1989-11-14 Norian Corporation In situ calcium phosphate minerals--method and composition
DE58902022D1 (en) * 1988-04-22 1992-09-17 Mathys Ag MARKER ROOM LOCK.
JPH0645487B2 (en) * 1989-05-19 1994-06-15 徳山曹達株式会社 Curing material
US5152791A (en) * 1989-12-07 1992-10-06 Olympus Optical Co., Ltd. Prosthetic artificial bone having ceramic layers of different porosity
US5164187A (en) * 1990-04-05 1992-11-17 Norian Corporation Hydroxyapatite prosthesis coatings
GB2246770B (en) 1990-07-27 1995-03-29 Osaka Cement Tetracalcium phosphate-based hardening materials
US5149368A (en) 1991-01-10 1992-09-22 Liu Sung Tsuen Resorbable bioactive calcium phosphate cement
US5262166A (en) 1991-04-17 1993-11-16 Lty Medical Inc Resorbable bioactive phosphate containing cements
DE4121043A1 (en) * 1991-06-26 1993-01-07 Merck Patent Gmbh BONE REPLACEMENT MATERIAL WITH FGF
EP0520690B1 (en) 1991-06-26 1995-11-02 Nitta Gelatin Inc. Calcium phosphate type hardening material for repairing living hard tissue
US5782971B1 (en) * 1991-06-28 1999-09-21 Norian Corp Calcium phosphate cements comprising amorophous calcium phosphate
US5338356A (en) * 1991-10-29 1994-08-16 Mitsubishi Materials Corporation Calcium phosphate granular cement and method for producing same
US5605713A (en) * 1991-11-22 1997-02-25 Boltong; Maria G. Process for the preparation of calcium phosphate cements and its application as bio-materials
US5218035A (en) * 1992-02-03 1993-06-08 Liu Sung Tsuen Phosphate-containing surgical cements
US6013853A (en) * 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
JP3170059B2 (en) 1992-08-25 2001-05-28 誠 大塚 Calcium phosphate drug sustained-release body and method for producing the same
JP3012095B2 (en) * 1992-10-08 2000-02-21 京セラ株式会社 Porous bioprosthesis member and processing method for imparting elasticity thereto
US5522893A (en) * 1993-03-12 1996-06-04 American Dental Association Health Foundation Calcium phosphate hydroxyapatite precursor and methods for making and using the same
US5476647A (en) * 1993-09-13 1995-12-19 American Dental Association Health Foundation Complex calcium and fluoride containing mouth rinses, dentifrices, and chewable tablets
US5525148A (en) * 1993-09-24 1996-06-11 American Dental Association Health Foundation Self-setting calcium phosphate cements and methods for preparing and using them
US5503164A (en) 1994-01-28 1996-04-02 Osteogenics, Inc. Device and method for repair of craniomaxillofacial bone defects including burr holes
DE4404018A1 (en) * 1994-02-09 1995-08-10 Merck Patent Gmbh Protected release dosage forms containing clindamycin palmitate
EP0734735B1 (en) 1994-10-13 2002-01-16 Kuraray Co., Ltd. Hard-tissue repair composition based on dimethacrylate monomers and supply unit therefor
CA2209556A1 (en) * 1995-01-06 1996-07-11 American Dental Association Health Foundation Control of calcium fluoride formation in mouth rinses, dentifrices and gels
US5550172A (en) * 1995-02-07 1996-08-27 Ethicon, Inc. Utilization of biocompatible adhesive/sealant materials for securing surgical devices
US6027742A (en) * 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US6117456A (en) * 1995-05-19 2000-09-12 Etex Corporation Methods and products related to the physical conversion of reactive amorphous calcium phosphate
US6132463A (en) * 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US5676976A (en) 1995-05-19 1997-10-14 Etex Corporation Synthesis of reactive amorphous calcium phosphates
US5702449A (en) 1995-06-07 1997-12-30 Danek Medical, Inc. Reinforced porous spinal implants
JPH0956805A (en) * 1995-08-24 1997-03-04 Millennium Biologics Inc Improved sintering method for thin film manufacturing of calcium phosphate material
CN1183058C (en) 1995-09-01 2005-01-05 米列姆·贝尔罗吉克公司 Artificial stabilized composition of calcium phosphate phases particularly adapted for supporting bone cell activity
WO1997045147A1 (en) * 1996-05-28 1997-12-04 1218122 Ontario Inc. Resorbable implant biomaterial made of condensed calcium phosphate particles
US6953594B2 (en) 1996-10-10 2005-10-11 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
US6149655A (en) * 1996-12-13 2000-11-21 Norian Corporation Methods and devices for the preparation, storage and administration of calcium phosphate cements
US5939039A (en) 1997-01-16 1999-08-17 Orthovita, Inc. Methods for production of calcium phosphate
US6013591A (en) * 1997-01-16 2000-01-11 Massachusetts Institute Of Technology Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production
DE69809158T2 (en) * 1997-08-28 2003-03-20 Ngk Spark Plug Co Calcium phosphate cement and calcium phosphate cement composition
US5899939A (en) * 1998-01-21 1999-05-04 Osteotech, Inc. Bone-derived implant for load-supporting applications
US6123731A (en) * 1998-02-06 2000-09-26 Osteotech, Inc. Osteoimplant and method for its manufacture
US5958430A (en) * 1998-02-20 1999-09-28 Battelle Memorial Institute Thin film composition with biological substance and method of making
US6139585A (en) * 1998-03-11 2000-10-31 Depuy Orthopaedics, Inc. Bioactive ceramic coating and method
US6294187B1 (en) * 1999-02-23 2001-09-25 Osteotech, Inc. Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same
US6696073B2 (en) * 1999-02-23 2004-02-24 Osteotech, Inc. Shaped load-bearing osteoimplant and methods of making same
JP3400740B2 (en) * 1999-04-13 2003-04-28 東芝セラミックス株式会社 Calcium phosphate porous sintered body and method for producing the same
SE515695C2 (en) * 1999-05-31 2001-09-24 Nobel Biocare Ab Implant with coating of bone growth stimulant for bone application and procedure in such implant
US6277149B1 (en) * 1999-06-08 2001-08-21 Osteotech, Inc. Ramp-shaped intervertebral implant
US7270705B2 (en) * 1999-07-14 2007-09-18 Jiin-Huey Chern Lin Method of increasing working time of tetracalcium phosphate cement paste
US7169373B2 (en) * 1999-07-14 2007-01-30 Calcitec, Inc. Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same
US6960249B2 (en) * 1999-07-14 2005-11-01 Calcitec, Inc. Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface
US6379453B1 (en) * 1999-07-14 2002-04-30 Jiin-Huey Chern Process for producing fast-setting, bioresorbable calcium phosphate cements
US7094282B2 (en) * 2000-07-13 2006-08-22 Calcitec, Inc. Calcium phosphate cement, use and preparation thereof
US6840995B2 (en) * 1999-07-14 2005-01-11 Calcitec, Inc. Process for producing fast-setting, bioresorbable calcium phosphate cements
US6458162B1 (en) 1999-08-13 2002-10-01 Vita Special Purpose Corporation Composite shaped bodies and methods for their production and use
US6162258A (en) * 1999-08-25 2000-12-19 Osteotech, Inc. Lyophilized monolithic bone implant and method for treating bone
JP4172883B2 (en) * 1999-09-08 2008-10-29 Hoya株式会社 Drug sustained release carrier and method for producing drug sustained release carrier
AU2001231264A1 (en) * 2000-01-31 2001-08-07 Advanced Research And Technology Institute, Inc. Composite biomaterial including anisometric calcium phosphate reinforcement particles and related methods
FR2805748B1 (en) * 2000-03-01 2002-09-13 Ceravic PROCESS FOR THE PREPARATION OF AN INJECTABLE PHOSPHOCALCIC PASTE MATERIAL FOR FORMING AN APATITIC BIOMATERIAL AND SURGICAL OR DENTAL APPLICATION
EP1153621A1 (en) 2000-05-12 2001-11-14 MERCK PATENT GmbH Biocements based on a mixture of TCP-PHA with improved compressive strength
US6533821B1 (en) * 2000-06-22 2003-03-18 Thomas Lally Bio-adhesive composition, method for adhering objects to bone
US6325804B1 (en) * 2000-06-28 2001-12-04 Ethicon, Inc. Method for fixing a graft in a bone tunnel
US6332779B1 (en) * 2000-07-03 2001-12-25 Osteotech, Inc. Method of hard tissue repair
DE60101967T2 (en) 2000-07-03 2004-07-22 Osteotech, Inc. BONE-FORMING IMPLANT FROM BONES
US20020062154A1 (en) * 2000-09-22 2002-05-23 Ayers Reed A. Non-uniform porosity tissue implant
EP1335887A4 (en) * 2000-10-16 2004-06-23 Univ South Carolina Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement
US6547866B1 (en) * 2000-10-30 2003-04-15 Howmedica Osteonics Corp. Porous calcium phosphate cement
JP4070951B2 (en) * 2000-12-07 2008-04-02 ペンタックス株式会社 Method for producing porous calcium phosphate ceramic sintered body
US6752831B2 (en) * 2000-12-08 2004-06-22 Osteotech, Inc. Biocompatible osteogenic band for repair of spinal disorders
US6793725B2 (en) * 2001-01-24 2004-09-21 Ada Foundation Premixed calcium phosphate cement pastes
US20030055512A1 (en) * 2001-05-21 2003-03-20 Genin Francois Y. Calcium based neutral and bioresorbable bone graft
US6616742B2 (en) * 2001-08-30 2003-09-09 Cana Lab Corporation Process for preparing a paste from calcium phosphate cement
US6478825B1 (en) * 2001-11-28 2002-11-12 Osteotech, Inc. Implant, method of making same and use of the implant for the treatment of bone defects
US7045105B2 (en) * 2001-12-21 2006-05-16 Lagow Richard J Calcium phosphate bone replacement materials and methods of use thereof
US6840961B2 (en) * 2001-12-21 2005-01-11 Etex Corporation Machinable preformed calcium phosphate bone substitute material implants
US6955716B2 (en) * 2002-03-01 2005-10-18 American Dental Association Foundation Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates
US20040137032A1 (en) * 2002-03-15 2004-07-15 Wang Francis W. Combinations of calcium phosphates, bone growth factors, and pore-forming additives as osteoconductive and osteoinductive composite bone grafts
US6648960B1 (en) * 2002-06-26 2003-11-18 Cana Lab Corporation Method of shortening a working and setting time of a calcium phosphate cement (CPC) paste
DE60300666T2 (en) * 2002-07-11 2006-04-27 Biomet Deutschland Gmbh Process for the preparation of porous calcium phosphate chips and granules from gelatine processing
CA2438742C (en) * 2002-08-27 2011-08-09 Merck Patent Gesellschaft Mit Beschraenkter Haftung A new calcium phosphate cement composition and a method for the preparation thereof
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
US7306610B2 (en) * 2003-03-21 2007-12-11 Cana Lab Corporation Method and device for forming a hardened cement in a bone cavity
US6994726B2 (en) * 2004-05-25 2006-02-07 Calcitec, Inc. Dual function prosthetic bone implant and method for preparing the same
US7163651B2 (en) * 2004-02-19 2007-01-16 Calcitec, Inc. Method for making a porous calcium phosphate article
US7118705B2 (en) * 2003-08-05 2006-10-10 Calcitec, Inc. Method for making a molded calcium phosphate article
WO2005046440A2 (en) * 2003-11-07 2005-05-26 Calcitec, Inc. Spinal fusion procedure using an injectable bone substitute

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496399A (en) * 1994-08-23 1996-03-05 Norian Corporation Storage stable calcium phosphate cements

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009096709A2 (en) * 2008-01-30 2009-08-06 Snu R & Db Foundation Bone cement with anion
WO2009096709A3 (en) * 2008-01-30 2009-11-05 서울대학교산학협력단 Bone cement with anion

Also Published As

Publication number Publication date
EP1613563A1 (en) 2006-01-11
US20050279252A1 (en) 2005-12-22
US20040003757A1 (en) 2004-01-08
US20050268820A1 (en) 2005-12-08
US7160381B2 (en) 2007-01-09
US6960249B2 (en) 2005-11-01

Similar Documents

Publication Publication Date Title
EP1613563A1 (en) Calcium phosphate cement, use and preparation thereof
US7258734B2 (en) Injectable calcium phosphate cements and the preparation and use thereof
US6616742B2 (en) Process for preparing a paste from calcium phosphate cement
EP0555807B1 (en) Bone substitute product and method of producing the same
US5149368A (en) Resorbable bioactive calcium phosphate cement
JP5441869B2 (en) Bone cement material and biosorbable hardened bone cement composite formed thereby
CN104853783B (en) Form composition, monetite cement, implant and the method for correcting Cranial defect of cement
JPS6017118A (en) Calcium phosphate fiber
CN111773432A (en) Magnesium-based amorphous-calcium phosphate/calcium silicate composite filler and preparation and application thereof
US5980625A (en) Calcium phosphate composition and a setting solution therefor
EP0415538B1 (en) Bioactive cement
EP0945119A2 (en) Calcium phosphate cements and calcium phosphate cement compositions
CN109276754A (en) A kind of somatotrophic injecting bone cement and preparation method thereof
EP1172076A2 (en) Calcium phosphate cement, use and preparation thereof
EP2450064B1 (en) Bone Cement Formula and Bioresorbable Hardened Bone Cement Composites Prepared with the Same
AU2004232948A1 (en) Calcium phosphate cement, use and preparation thereof
JP2001314497A (en) Composition of matter for biomaterial and hardened body thereof
US20070224286A1 (en) Process for Preparing Calcium Phosphate Self-Setting Bone Cement, the Cement So Prepared and Uses Thereof
Li et al. Reaction of hydroxyapatite-sol in bone marrow
JP3574396B2 (en) Calcium phosphate cement, its use and production method
KR20060091714A (en) Calcium phosphate cement, use and preparation thereof
JPH06172008A (en) Hardenable composition
JP3423951B2 (en) Calcium phosphate hardened powder
CN111773434A (en) Magnesium strontium-calcium phosphate/calcium silicate composite bone cement filler and preparation and application thereof
WO2012054010A1 (en) Bone cement formula and bioresorbable hardened bone cement composites prepared with the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2520367

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004750157

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004232948

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2006510072

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1020057019799

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2004232948

Country of ref document: AU

Date of ref document: 20040416

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004232948

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004750157

Country of ref document: EP

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWP Wipo information: published in national office

Ref document number: 1020057019799

Country of ref document: KR